| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000047456 |
| Receipt No. | R000054115 |
| Scientific Title | Remote visual ADL investigation for retinitis pigmentosa |
| Date of disclosure of the study information | 2022/04/11 |
| Last modified on | 2022/09/12 (Ver. 2) |
| Basic information | ||
| Public title | Remote visual ADL investigation for retinitis pigmentosa | |
| Acronym | Re-RP LVFAM prototype | |
| Scientific Title | Remote visual ADL investigation for retinitis pigmentosa | |
| Scientific Title:Acronym | Re-RP LVFAM prototype | |
| Region |
|
|
| Condition | ||
| Condition | retinitis pigmentosa | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Tolerability study of the new LVFAM, a modified version of the Visual ADL Questionnaire (LVFAM) for retinitis pigmentosa (RP) and remote use. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Tolerability Checklist |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Retinitis pigmentosa patients in the outpatient clinic of Chiba University Department of Ophthalmology
2) Visited between January 1, 2022 and September 30, 2022 3) History of Humphrey Field of View (HFA) 10-2 measurements 4) Corrected visual acuity in both eyes in the range of 0.2 to 0.9 |
|||
| Key exclusion criteria | (1) 20 years of age or older and less than 80 years of age
(3) Patients with other ophthalmologic diseases that affect visual function 4) Cases of blindness in one eye (5) Cases with significant fluctuations in visual function and findings |
|||
| Target sample size | 5 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Chiba University Hpspital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 260-8677 | ||||||
| Address | Chiba City, Chuo-ku, Inohana 1-8-1 | ||||||
| TEL | 0432227171 | ||||||
| takeshis@faculty.chiba-u.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Chiba University Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 260-8677 | ||||||
| Address | Chiba City, Chuo-ku, Inohana 1-8-1 | ||||||
| TEL | 0432227171 | ||||||
| Homepage URL | |||||||
| takeshis@faculty.chiba-u.jp | |||||||
| Sponsor | |
| Institute | Chiba University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Chiba University Hospital |
| Address | Chiba City, Chuo-ku, Inohana 1-8-1 |
| Tel | 0432227171 |
| takeshis@faculty.chiba-u.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | questionnaire survey |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054115 |